Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

Hiroe Kayatani, Kadoaki Ohashi, Kiichiro Ninomiya, Go Makimoto, Kazuya Nishii, Hisao Higo, Hiromi Watanabe, Hirohisa Kano, Yuka Kato, Takashi Ninomiya, Toshio Kubo, Kanmei Rai, Eiki Ichihara, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds